Medication info
Besilsartan Tablets 10/50 mg (Amlodipine, Losartan Potassium)

Besilsartan Tablets 10/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Light pink rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502640 · Approved 2015.04.30 · Insurance code 670607230

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by amlodipine or losartan alone. It is also used as an initial treatment in cases where combination therapy is required to reach the target blood pressure in patients with stage 2 hypertension. Therefore, it helps improve blood pressure control and prevent hypertension-related complications.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. Taking this medication during pregnancy may result in several dangerous symptoms, including reduced fetal kidney function, low blood pressure, cranial formation abnormalities, and pulmonary developmental issues. If unavoidable use is required early in pregnancy, the fetal health status should be periodically monitored via ultrasound or other means, and the medication should be stopped if any abnormal symptoms are found. Patients with decreased intravascular effective blood volume, such as those taking diuretics, should be cautious as hypotension may occur upon initiation of this medication. This medication should not be used in patients who are allergic to its components or similar medications, pregnant women or women of childbearing potential, breastfeeding women, patients with severe liver dysfunction, patients with severe aortic stenosis, or patients in shock. Caution is also warranted in patients with low blood volume or those on strict salt restriction, those with severe kidney dysfunction or on dialysis, and patients with hyperkalemia. Neurological symptoms such as dizziness, drowsiness, headache may occur while taking this medication, so operating high-risk machinery or driving should be avoided. If there are abnormalities in liver or kidney function, consult a doctor for appropriate dosage adjustment before taking this medication. When taken with other antihypertensive drugs, caution is advised as blood pressure may become too low, and grapefruit juice may enhance the effects, so it is best to avoid it. Pregnant or breastfeeding women should not take this medication, and if pregnancy is planned or confirmed, they should inform their healthcare provider immediately. Safety and efficacy in children and adolescents under 18 years have not been established, so its use is not recommended. In case of overdose, severe hypotension or heart rhythm abnormalities may occur, so appropriate treatment should be sought immediately at a medical facility. This medication should be kept out of reach of children and should not be transferred to other containers to maintain its quality.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb spasticity
  • craniofacial deformities
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 193 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension elevation
  • sensory reduction
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • dermal erythema
  • maculopapular rash
  • tinnitus
  • heat sensation
  • diminished glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin exfoliation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • nerve hypersensitivity
  • panic disorder
  • sleep disorder
  • bronchitis
  • throat discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • dermatitis
  • skin dryness
  • petechia
  • erythema
  • photodermatitis
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • visual impairment
  • urethral infection
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythematous skin syndrome
  • hyperkalemia
  • hyponatremia
  • hypotension
  • loss of consciousness
  • shock symptoms
  • hypotension
  • reflex tachycardia
  • systemic hypotension
  • severe hypotension
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Light pink rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.